NAD+

35 studies on NAD+ curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

2025-11-01 PubMed

Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial.
2026-03-01 PubMed

Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration.
2026-01-01 PubMed

The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans.
2026-03-31 PubMed

Metabolic reprogramming of neurons in alzheimer disease: a biochemical perspective.
2026-05-01 PubMed

Beyond disease treatment and prevention: From geroscience and molecular hallmarks to gerotherapeutics and precision geromedicine.
2026-05-01 PubMed

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.
2026-05-15 PubMed

Effect of Sevelamer and B. longum on Insulin Sensitivity in Participants With Obesity: A Randomized Clinical Trial.
2026-01-01 PubMed

Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial.
2026-05-23 PubMed

Regenerative Approaches to Enhance the Skin Microenvironment and Boost Aesthetic Efficacy: A Narrative Review.
2026-05-29 PubMed

Skin Cancer Prevention and Antiaging: Role of Nicotinamide.
2026-05-30 PubMed

Nutritional Regulation of Ovarian Bioenergetics: Implications for Reproductive Aging and Female Infertility.
2026-01-01 PubMed

Sex-specific differences in vascular circulation and metabolic regulation associated with aging and cardiovascular health problems.
2026-01-01 PubMed

Beyond cartilage degeneration: osteoarthritis as a systems failure of inflammation regulation.
2026-06-01 PubMed

Posttraumatic Stress Disorder (PTSD) NAD/Sirtuin Deficiency and SARM1-Mediated Synaptic Vulnerability: Evidence for Accelerated Brain Aging Subtypes.
2026-06-01 PubMed

Opposing Molecular Programs in Obsessive-Compulsive Disorder and Hoarding: Transcriptome-Wide Association Studies Reveal Distinct Senescence, Complement, and Metabolic Signatures.
2026-06-09 PubMed

Antiaging Effects of Mannose-6-Phosphate through Enhanced Mitochondrial Function and Collagen Remodeling.
2026-06-02 PubMed

Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness.
2026-01-01 PubMed

NMN protects vascular endothelial cells from M1 macrophage-derived IL-1β-induced hyperpermeability by inhibiting VE-cadherin degradation.
2026-06-11 PubMed

Restoration of mitochondrial dynamics and synaptic function by mitophagy enhancers in a tauopathy cell model.
2026-01-01 PubMed

Integrated transcriptomic and metabolomic identification of the core pathway of photosynthetic carbon fixation in mung bean under saline-alkali stress.
2026-01-01 PubMed

Turning back time: a comprehensive list of interventions that decrease next-generation epigenetic aging clocks in humans.
2026-06-04 PubMed

Mitochondrial-impaired ductal epithelium fuels TLS formation in Sjögren's disease.
2026-01-01 PubMed

[Sleep disorders and chronic cerebral ischemia].
2026-05-22 PubMed

Molecular Engineering of Nicotinamide Riboside Kinase and Process Optimization for Efficient Nicotinamide Mononucleotide Production.
2026-06-12 PubMed

Development of a Noncanonical Redox Cofactor Platform in Saccharomyces cerevisiae.
2026-01-01 PubMed

Preliminary exploration of acute limit toxicity testing for nicotinamide mononucleotide in the neonatal population.
2026-06-16 PubMed

Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men.
2026-05-08 PubMed

A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD.
2026-06-01 PubMed

Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice.
2026-10-01 PubMed

A sustained NAD+ supplementation-biosynthesis nanoplatform for metabolic restoration in aged bone regeneration.
2026-06-03 PubMed

Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits.
2026-01-01 PubMed

Niacinamide modulation by hemocyanin shapes hemolymph microbial communities in Penaeid shrimp.
2026-06-05 PubMed

DHDDS-related juvenile parkinsonism is caused by impaired lipid metabolism, glycosylation, and mitochondrial dysfunction, which can be rescued by NAD⁺ treatment.
2026-01-01 PubMed

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities.
2026-06-15 PubMed

Sex Dimorphism of NAD+De Novo Biosynthesis Mediates Sex-Biased Susceptibility to Ischemia-Reperfusion-Induced Acute Kidney Injury.

Research tools

Free, no account — handy when you're working with NAD+.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

You are looking at the free layer

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Create free account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.